Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
Open Access
- 18 June 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 9909
Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals out of a cohort of 327 individuals suspected of TSC. A total of 137 predicted pathogenic or likely pathogenic variants were identified: 33 different TSC1 variants in 42 patients, and 104 different TSC2 variants in 126 patients. In 40 cases (24%), the identified predicted pathogenic variant had not been described previously. In total, 33 novel variants in TSC2 and 7 novel variants in TSC1 were identified. To assist in the classification of 11 TSC2 variants, we investigated the effects of these variants in an in vitro functional assay. Based on the functional results, as well as population and genetic data, we classified 8 variants as likely to be pathogenic and 3 as likely to be benign.Keywords
Funding Information
- Tuberous Sclerosis Alliance ((USA)(06-16) and CAPES (Brazil)(Process:88881.132401/2016-01).)
- Det Frie Forskningsråd (12-127196)
- Aase og Ejnar Danielsens Fond (10-000748)
This publication has 36 references indexed in Scilit:
- Genetics, genomics, and genotype–phenotype correlations of TSC: Insights for clinical practiceAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2018
- Structure of the TBC1D7–TSC1 complex reveals that TBC1D7 stabilizes dimerization of the TSC1 C-terminal coiled coil regionJournal of Molecular Cell Biology, 2016
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic reviewCurrent Medical Research and Opinion, 2011
- Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United StatesGenetics in Medicine, 2007
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes & Development, 2003
- Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple OrgansThe American Journal of Human Genetics, 2001
- Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34Science, 1997
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993
- Epidemiology of Tuberous SclerosisAnnals of the New York Academy of Sciences, 1991